Table 1.
Patient characteristics. GS and TNM are based on whole-mount histopathological sections from radical prostatectomy
| Cohort I | Cohort II | |
|---|---|---|
| Median (Range) | ||
| Age (y) | 62 (51–74) | 70 (53–80) |
| PSA at imaging (ng/ml) | 16,9 (6,1–218,0) | 17,4 (4,3–108,0) |
| Time between PET and RP (d) | 29 (1–159) | 25 (1–43) |
| GTV in PSMA PET (ml) | 10,3 (0,8–87,7) | 5,5 (0,6–48,6) |
| Frequency (%) | ||
| pT2a | 0 | 21 |
| pT2c | 39 | 14 |
| pT3a | 28 | 36 |
| pT3b | 33 | 29 |
| pN0 | 61 | 86 |
| pN1 | 39 | 14 |
| GS 7a | 39 | 0 |
| GS 7b | 28 | 50 |
| GS 8 | 22 | 21 |
| GS 9 | 11 | 29 |